Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension

Journal of the Renin-angiotensin-aldosterone System : JRAAS
Yagiz UresinAndrew Satlin

Abstract

To assess the antihypertensive efficacy and safety of the combination of the direct renin inhibitor aliskiren and ramipril in patients with diabetes and hypertension. In this double-blind, multicentre trial, 837 patients with diabetes mellitus and hypertension (mean sitting diastolic blood pressure [BP] > 95 and < 110 mmHg) were randomised to once-daily aliskiren (150 mg titrated to 300 mg after four weeks; n=282), ramipril (5 mg titrated to 10 mg; n=278) or the combination (n=277) for eight weeks. Efficacy variables were cuff mean sitting diastolic BP (msDBP) and mean sitting systolic BP (msSBP); 24-hour ambulatory BP, plasma renin activity (PRA) and plasma renin concentration (PRC) were also assessed. At week 8, aliskiren, ramipril and aliskiren/ramipril lowered msDBP (mean+/-SEM) by 11.3+/-0.5, 10.7+/-0.5 and 12.8+/-0.5 mmHg, and msSBP by 14.7+/-0.9, 12.0+/-0.9 and 16.6+/-0.9 mmHg, respectively. Aliskiren/ramipril provided superior msDBP reductions to ramipril (p=0.004) or aliskiren (p=0.043) monotherapy; adding aliskiren to ramipril provided an additional mean BP reduction of 4.6/2.1 mmHg. Aliskiren monotherapy was non-inferior to ramipril for msDBP reduction (p=0.0002) and superior for msSBP reduction (p=0.021). All treatm...Continue Reading

References

Nov 1, 1985·Journal of Cardiovascular Pharmacology·P W de LeeuwW H Birkenhäger
Nov 1, 1965·Proceedings of the Society for Experimental Biology and Medicine·A J Vander, G W Geelhoed
Jan 1, 1994·Clinical Pharmacokinetics·S MeiselT Rosenthal
Mar 1, 1993·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·J L RodicioL M Ruilope
Nov 1, 1995·Journal of Biopharmaceutical Statistics·T Morikawa, M Yoshida
Mar 15, 2001·Blood Pressure Monitoring·J M Neutel
May 24, 2001·American Journal of Hypertension·F H MesserliU Goldbourt
Sep 22, 2001·The New England Journal of Medicine·H H ParvingUNKNOWN Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jun 5, 2003·Journal of Hypertension·UNKNOWN European Society of Hypertension-European Society of Cardiology Guidelines Committee
Nov 12, 2003·The New England Journal of Medicine·Marc A PfefferUNKNOWN Valsartan in Acute Myocardial Infarction Trial Investigators
Mar 11, 2004·Current Hypertension Reports·Donna S HanesMatthew R Weir
Nov 2, 2004·The New England Journal of Medicine·Piero RuggenentiUNKNOWN Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators
Feb 11, 2005·Journal of the American Society of Nephrology : JASN·Naomi D L Fisher, Norman K Hollenberg
Apr 6, 2005·Trends in Endocrinology and Metabolism : TEM·Gilberta GiacchettiRobert M Carey
Mar 9, 2006·The Journal of Clinical Hypertension·Karen A Griffin

❮ Previous
Next ❯

Citations

May 22, 2010·Cardiovascular Drugs and Therapy·Christian W Mende
Dec 8, 2011·Cardiovascular Drugs and Therapy·Osamu Tsukamoto, Masafumi Kitakaze
Jan 18, 2013·International Urology and Nephrology·Sławomir LizakowskiBolesław Rutkowski
Oct 19, 2011·Journal of General Internal Medicine·Emaad M Abdel-RahmanAlaa S Awad
Apr 25, 2012·Current Heart Failure Reports·Gabriel WagmanTimothy J Vittorio
Mar 13, 2009·Current Hypertension Reports·Rajesh KumarKenneth M Baker
Nov 10, 2009·Current Hypertension Reports·Rekha Pinto, Alan H Gradman
Sep 29, 2012·Clinical Pharmacokinetics·Dmytro KhadzhynovHarm Peters
Sep 9, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Jun-Ren ZhuUNKNOWN trial investigators
Dec 25, 2009·Journal of Human Hypertension·D A DuprezA N Charney
Mar 15, 2008·Nature Reviews. Drug Discovery·Chris JensenHans Rudolf Brunner
Jun 6, 2008·The New England Journal of Medicine·Julie R Ingelfinger
Jun 6, 2008·The New England Journal of Medicine·Hans-Henrik ParvingUNKNOWN AVOID Study Investigators
Sep 30, 2008·Antioxidants & Redox Signaling·Ravi NistalaJames R Sowers
Jun 18, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sydney C W TangKar Neng Lai
Nov 5, 2008·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·David Barit, Mark E Cooper
Sep 4, 2009·Journal of Hypertension·Hiddo J Lambers HeerspinkDick de Zeeuw
Apr 9, 2010·Journal of Hypertension·Yi-Fei DongShokei Kim-Mitsuyama
Aug 27, 2009·The Journal of Cardiovascular Nursing·Mary Ellen Roberts, Benjamin J Epstein
May 19, 2010·American Journal of Therapeutics·Zafar H IsrailiValmore Bermúdez
Mar 26, 2011·American Journal of Therapeutics·Angela Brown, Becky Captain
Feb 15, 2011·American Journal of Therapeutics·Addison A Taylor, James L Pool
Aug 13, 2008·Current Opinion in Nephrology and Hypertension·Krishna K Gaddam, Suzanne Oparil
Jul 9, 2009·Current Opinion in Nephrology and Hypertension·Aldo J Peixoto, Marcelo Orias
Feb 11, 2012·International Journal of Clinical Practice·U ZeymerUNKNOWN 3A Registry Investigators
Jan 30, 2013·BMJ : British Medical Journal·Harikrishna MakaniFranz H Messerli
Jun 8, 2012·American Journal of Physiology. Renal Physiology·Jun ZhangJeffrey D Peterson
May 3, 2013·Cardiology·Massimo Volpe, Thomas Unger
Apr 23, 2010·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Motoharu TanakaHiromi Goto
Jun 23, 2011·International Journal of Nephrology and Renovascular Disease·Hernán Trimarchi
Aug 24, 2010·Vascular Health and Risk Management·Francesca CagnoniMaurizio Destro
Oct 20, 2010·Vascular Health and Risk Management·Roberto Fogari, Annalisa Zoppi
May 30, 2009·Vascular Health and Risk Management·Gianpaolo ReboldiPaolo Verdecchia
Sep 23, 2010·Vascular Health and Risk Management·Benjamin J Epstein
Nov 26, 2010·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Vivencio Barrios, Carlos Escobar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.